GLP-1 Guide — Insurance & Prior Authorization

Best GLP-1 Providers That Provide a Letter of Medical Necessity

Published: June 15, 2026 · Last reviewed: June 15, 2026

By The RX Index Editorial Team · The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers.

Last verified: June 15, 2026

If you need a letter of medical necessity to get your GLP-1 covered or paid back, the fastest path for most people is Ro. Out of the best GLP-1 providers that provide a letter of medical necessity, Ro stands out for one reason: its insurance concierge checks your coverage, files the prior-authorization paperwork, and fights denials for you. Per Ro’s own appeal guidance, that paperwork can include a letter of medical necessity — for FDA-approved drugs like Wegovy, Zepbound, Ozempic, and the new Foundayo pill. Want to pick your own doctor instead? Sesame is the strong runner-up. Just paying cash and need the letter for your HSA or FSA? Noom and Mochi both put one in writing on request.

One honest catch, right up front: a letter helps a fixable denial. It usually can’t force a plan that flat-out refuses to cover any weight-loss drug to pay. We’ll show you how to tell the difference in about two minutes — and exactly who to start with for your situation.

A letter of medical necessity (LMN) is a short note from a licensed clinician. It says you have a real, diagnosed health problem and that your GLP-1 treats it. People use it for two very different jobs: getting insurance to cover the drug, or getting an HSA/FSA to pay you back. Picking the right provider depends on which job you have.

Quick pick: who to start with

Not sure what paperwork you actually need? Use the LMN Path Finder below. Answer four quick questions — insurance or HSA/FSA, brand or compounded, your denial reason (if you have one), and your diagnosis — and we’ll tell you whether to ask for a letter, chase prior authorization, file an appeal, or skip straight to cash-pay. It takes under a minute, and it’s the fastest way to stop guessing.

What are the best GLP-1 providers that provide a letter of medical necessity?

The best overall pick is Ro, because its insurance concierge handles the whole paperwork path for eligible FDA-approved GLP-1s — coverage checks, prior authorization, insurer communication, and appeals — and per Ro’s appeal guidance, that paperwork can include a letter of medical necessity. Sesame is the top runner-up for people who want to choose their own clinician, while Noom and Mochi are the clearest picks when you only need the letter for HSA or FSA reimbursement. Many telehealth clinics can write a letter — the real difference is which one does the rest of the work for you.

Here’s the thing almost no other page tells you: “accepts insurance,” “helps with prior authorization,” and “writes a letter of medical necessity” are three different things. A clinic can do one and not the others. So we checked. Below is what each major provider actually documents — pulled from their own websites and official manufacturer guides, with the date we confirmed it.

The RX Index GLP-1 Letter of Medical Necessity Verification Table

Every row was checked against the provider’s own pages or stated policy on June 15, 2026. Full sources are listed in the “How we verified this page” section below.

A quick note on the table: we list Mochi, Noom, and Form even though they aren’t our paid partners. They belong here because they’re real, documented options, and a comparison you can trust has to include them. Our paid relationships are with Ro and Sesame — which also happen to be the best fits for the most common reason people land on this page (getting a brand-name drug covered). We’ll always tell you when a free or non-partner option is the smarter move for you.

Letter of medical necessity vs. prior authorization: which do you need?

A letter of medical necessity is not the same as prior authorization. Prior authorization is your insurance company’s approval process — its “yes” before it pays. A letter is supporting paperwork from your clinician that can strengthen that request or an appeal. And there are two separate reasons to get a letter: to get insurance to cover the drug, or to get your HSA/FSA to pay you back. Those go to different providers.

Mixing these up is the #1 mistake. So here’s the simple split:

Job 1 — You want insurance to pay for the drug. You’re trying to turn a $1,000-plus monthly cost into a copay. This is the harder job. You usually need a brand-name, FDA-approved GLP-1, and your doctor has to file a prior authorization (when your insurance must say “yes” before it pays). If they say no, you appeal — and that’s where a strong letter matters most. Best picks: Ro, then Sesame.

Job 2 — You’re paying cash and want your HSA/FSA to pay you back. Your money is already set aside, tax-free. You just need proof the expense is medical. Most of the time a prescription and an itemized receipt are enough. When your account asks for more, that’s when you hand over the letter. This works for brand drugs and, in many cases, compounded ones too. Best picks: any provider that writes the letter — Noom, Mochi, or your own prescriber.

If you’re not sure which job is yours, that’s normal. Keep reading — or jump to the 60-second matching quiz and we’ll point you to the right path.

Ro — best for getting insurance to cover your GLP-1

Ro is the strongest pick when your goal is insurance coverage. Its insurance concierge checks your benefits, files the prior authorization, communicates with your insurer, and fights denials for FDA-approved drugs like Wegovy, Zepbound, Ozempic, and Foundayo. Per Ro’s own appeal guidance, that paperwork can include a letter of medical necessity and clinical notes. Membership starts at $39 for the first month, then as low as $74/month on an annual plan paid upfront.

Most people don’t need a generic letter. They need someone to handle the paperwork war that turns a $1,000 medicine into a $25 copay. That’s exactly what Ro built. Per Ro’s own site, its concierge verifies your benefits, submits prior authorization, “submits all paperwork on your behalf,” and keeps fighting if you’re denied — suggesting other FDA-approved options if your first choice isn’t covered.

Ro is also clean on the medicine itself. It offers FDA-approved brands — Wegovy (pen and pill), Zepbound (vials and KwikPen), Ozempic, Foundayo, and Saxenda — at the same cash prices as the makers’ own pharmacies (NovoCare, LillyDirect, and TrumpRx). If you use insurance, your cost may just be your copay, depending on what your plan covers.

The honest downside: Ro is not the cheapest path on paper. The membership is real money on top of the drug — $39 the first month, then as low as $74/month if you prepay for a year (otherwise around $149/month). And if you already have a doctor willing to prescribe, you can sometimes get the same brand-name drug at the same cash price straight from NovoCare or LillyDirect, with no membership at all. If a rock-bottom sticker price is your only goal, manufacturer-direct is cheaper — start there.

But here’s why thousands of people pay for Ro anyway: the membership isn’t buying the pills. It’s buying the team that files your prior authorization and fights your denial — the hours of phone calls and fax forms that defeat most people on their own. If paperwork is the reason you’re reading this page, that’s the exact thing you’re paying for. And the math can flip fast: get approved, and a $74 membership plus a $25 copay beats paying $500–$1,000 cash every month. (Want the full breakdown? Read our Ro review.)

Ro works best if you:

• Have commercial (job or marketplace) insurance and want a brand-name GLP-1 considered.
• Are tired of fighting your insurer alone.
• Tried your regular doctor and they don’t prescribe GLP-1s or don’t know the prior-auth process.

Ro is not the best fit if you already know your plan excludes all weight-loss drugs, or you only want the fastest cash-pay option. If that’s you, skip ahead to the cash-pay and denial sections so you don’t waste a month.

Sesame — best if you want to choose your own clinician

Sesame is the top runner-up. It’s a marketplace where you pick your own clinician, and its providers assist with prior authorization paperwork for brand-name GLP-1s like Wegovy and Zepbound. For some covered brand-name drugs, eligible commercially insured patients may pay as little as $25/month with manufacturer savings.

Some people don’t want a one-size membership. They want to read reviews, choose a clinician, and ask questions before they commit. That’s Sesame. Per Sesame’s own pages, your provider can help with prior-authorization paperwork to bring your cost down, and the program offers the widest brand-name menu we found — Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, and Saxenda. The “Success by Sesame” program runs roughly $59–$99/month for the care, with the medicine billed separately. Costco members get a discount.

One thing to know: on Sesame, each provider sets their own scope and price. So prior-auth help — and a standalone letter of medical necessity — can vary from clinician to clinician. That’s actually a feature if you use it right.

Just using HSA or FSA? Noom and Mochi put the letter in writing

If you’re paying cash and only need a letter to get your HSA or FSA to reimburse you, two providers state they’ll write one: Noom Med and Mochi Health. You can also simply ask your own prescriber — most clinicians can write a letter if they’re willing and have your records.

This is the easier job, and it doesn’t need a big membership. Here’s the difference between the two:

Noom Med doesn’t take HSA/FSA cards directly. But per Noom’s own support pages, you can ask your clinician for a letter of medical necessity, then submit it with your receipt to get reimbursed. Good fit if you’re already a Noom member or you want coaching built in.

Mochi Health accepts HSA/FSA cards at checkout, and per its stated policy, it will provide a letter of medical necessity on request if your card processor needs documentation. Mochi also says its team helps with insurance questions, including prior authorizations and letters. One tip before you rely on it: confirm the letter is written for reimbursement and that you’ll also get the itemized receipt your account may ask for.

Either way, do this one thing: ask for the letter the day your prescription is written, while your diagnosis, medication, and records are fresh. It saves you a scramble later if your account flags the claim.

Form Health — best if you want to use in-network insurance

Form Health is the best fit when you want your insurance billed for your visits, not just your medicine. Per its own site, Form works with most major private insurance plans and Medicare, pairs you with a board-certified obesity-medicine physician, and its care team files prior authorizations and advocates for coverage.

Ro and Sesame help your insurance cover the drug, but the membership or visit is usually cash. Form is different: it bills insurance for the care itself, and it specializes in obesity medicine. You fill prescriptions at your own pharmacy, so the medicine cost doesn’t change. Form only prescribes FDA-approved drugs — no compounded options — which keeps your insurance and documentation clean.

Form doesn’t loudly advertise a “letter of medical necessity,” so confirm that at your intake visit. But if you want a specialist, in-network billing, or Medicare support, Form is a genuinely strong choice — and we’d point you there over a flashier option if that’s what fits.

A few other insurance-billing programs — PlushCare, Calibrate, and WeightWatchers Clinic — also help with prior authorization per their own materials. They can be worth a look, but check current details directly, since program features change.

What a strong GLP-1 letter of medical necessity must include

A strong letter does more than say the medicine “would help.” It matches your insurer’s exact rules. It should name your diagnosis and code, your BMI now and before, any related health conditions, the specific drug requested, what you’ve already tried, and why this drug is medically necessary — signed by your clinician.

Both drug makers actually publish guides for this. Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) each provide a template and a list of what to include — proof that the letter is a normal, expected part of the process, not a long shot.

Here’s the checklist. Bring it to your visit:

1. Your name and date of birth.
2. Your clinician’s name, credentials, NPI number, signature, and the date.
3. Your diagnosis and its code (for example, obesity is coded under ICD-10 E66).
4. Your current BMI and your starting BMI, with dates.
5. Related health conditions (type 2 diabetes, high blood pressure, sleep apnea, heart disease, high cholesterol).
6. The exact drug and form requested (for example, “Zepbound vials, 5 mg”).
7. What you’ve already tried — diet programs, other medicines, how long, and what happened.
8. Any reasons other drugs won’t work (side effects, allergies, or they didn’t help).
9. Recent labs and chart notes.
10. A direct answer to the plan’s denial reason or rules.

Why generic letters fail: they don’t name the exact drug, they skip your BMI or diagnosis, they argue “general wellness” instead of a real medical condition, or they ignore “step therapy” (when your plan makes you try cheaper drugs first). A good provider knows this. That’s the whole point of choosing one that handles the paperwork.

Will a letter actually get Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo covered?

Sometimes — but only when the denial is fixable and the drug matches your plan’s rules. A letter is most powerful for missing paperwork, wrong codes, “step therapy,” “not on formulary,” and appeals. It’s weakest when your plan excludes all weight-loss drugs. A denial gets overturned more often than people expect, so it’s often not the end.

Coverage depends a lot on the drug and your diagnosis. Here’s the plain-language version:

Wegovy (semaglutide). FDA-approved for weight management. Per Novo Nordisk’s provider site, if Wegovy isn’t on your plan’s list of covered drugs (its “formulary”), your provider can submit a formulary exception request plus a letter of medical necessity. If your plan flatly excludes obesity drugs, that usually gets an automatic “no” — but if you have heart disease plus obesity or overweight, there may be a covered path, since Wegovy also has a heart-related use.

Zepbound (tirzepatide). FDA-approved for weight management and for obstructive sleep apnea. Per Lilly’s Zepbound site, your provider can submit prior authorization with a letter of medical necessity, and if you’re denied, they can appeal — and should add the letter if it wasn’t included the first time.

Foundayo (orforglipron). This is the new once-a-day GLP-1 pill, FDA-approved on April 1, 2026 for adults with obesity, or overweight plus at least one weight-related health condition, alongside a reduced-calorie diet and more activity. Because it’s brand-name and FDA-approved, take it through Ro or Sesame — not a compounded provider. Self-pay starts at $149/month for the lowest dose. Eligible commercially insured patients with Foundayo coverage may pay as little as $25/month with the maker’s savings card, and eligible Medicare Part D members can pay no more than $50/month beginning July 1, 2026. Coverage rules are brand-new and changing fast, so check current status.

Ozempic and Mounjaro. These are diabetes drugs first. If you have type 2 diabetes, they fit their FDA-approved use, so coverage is more likely — though your plan can still require prior authorization. If you don’t have diabetes, getting them covered for weight loss alone is much harder, because your plan covers them for diabetes, not weight. Never ask a provider to write down a diagnosis you don’t have. That’s fraud, and it can hurt you. If weight loss is your goal, a weight-approved drug like Wegovy, Zepbound, or Foundayo is the honest route.

Which denials a letter can fix (and which it can’t)

One more honest note: a true benefit exclusion (your plan simply doesn’t cover weight-loss drugs) often can’t even be appealed. The exception is if you qualify under a different, covered reason. If you’re stuck there, don’t spend months fighting — jump to cash-pay below.

Can you use a letter of medical necessity for HSA or FSA?

Yes, in many cases — but a letter here is about reimbursement, not insurance coverage. IRS rules let you use HSA/FSA money for weight-loss treatment when a doctor prescribes it for a specific diagnosed disease (like obesity, diabetes, or heart disease), not for general wellness or looks. Keep your prescription, an itemized receipt, and the letter.

Insurance coverage and HSA/FSA are two separate things. Insurance decides if your plan pays. HSA/FSA decides if you can use your own pre-tax dollars. You can use HSA/FSA money even when insurance won’t cover the drug — as long as it’s prescribed for a real medical condition. (Per IRS Publication 502, weight-loss costs count when treating a disease diagnosed by a physician.) For the full mechanics, see our HSA guide and FSA guide.

A few specifics worth knowing:

• For 2026, the FSA limit is $3,400 per person, and many plans are “use it or lose it” at year-end. HSA limits are $4,400 for individuals and $8,750 for families, and HSA money rolls over forever — you can even pay yourself back years later if you keep the receipts.
• How long a letter lasts depends on your insurer or HSA/FSA administrator. Many are treated as valid for about a year, but some use shorter windows. Use the date on the letter and confirm with your administrator before you rely on it.
• For a drug clearly approved for your condition (Wegovy or Zepbound for obesity), documentation is simple. For off-label use (Ozempic for weight loss when you don’t have diabetes), expect to need a letter.

Easiest path to HSA/FSA documentation, by situation

That last row matters. At least one budget provider, Yucca Health, states it does not provide itemized receipts or letters of medical necessity. That’s fine if you’ll never need to file a claim — but if HSA/FSA is your whole reason for choosing, it’s a dealbreaker. Pick a provider that documents.

Does a letter of medical necessity work for compounded GLP-1s?

No — a letter does not make insurance pay for a compounded GLP-1. Insurers almost never cover compounded versions, and a letter doesn’t change that or change a drug’s FDA status. For HSA/FSA, IRS rules allow prescribed treatment of a diagnosed disease, so a prescription plus a letter and an itemized receipt can support a claim — but compounded products can draw extra scrutiny, so confirm with your administrator first.

Quick definition: compounded drugs are mixed by a pharmacy for an individual patient. They are not FDA-approved, and the FDA does not review them for safety, quality, or effectiveness before they’re sold. The FDA has also reported safety problems tied to compounded semaglutide and tirzepatide, including dosing errors, wrong “salt forms” of the drug, improper shipping or storage, and fraudulent or unapproved products sold online.

The legal picture also shifted recently. The FDA declared the shortages over (tirzepatide in December 2024, semaglutide on February 21, 2025). With the shortage pathway closed, broad copy-style compounding is under more pressure, and pharmacies generally must justify it by an individual patient’s medical need. On April 30, 2026, the FDA also proposed removing semaglutide, tirzepatide, and liraglutide from a key list that outsourcing pharmacies rely on — a proposal that is not final as of this update. Translation: compounded GLP-1s still exist, but they’re under real regulatory pressure.

What this means for you: if you want to use HSA/FSA money on a cash-pay compounded drug, a letter can support that claim (confirm with your administrator). But if your goal is insurance coverage, a compounded drug is the wrong tool — and a letter won’t fix it. For coverage, you want an FDA-approved brand and a provider who fights for it. Back to Ro and Sesame.

What to do if your GLP-1 is denied — even with a letter

Read the denial letter first, word for word. The reason it gives controls everything you do next. If it’s missing paperwork, a wrong code, step therapy, or “not on formulary,” a better letter and an appeal often win. If it’s a hard exclusion, a cash-pay path is usually the smarter move.

Here’s the simple plan:

1. Get the denial in writing and find the exact reason.
2. Ask your plan what criteria it used (BMI, conditions, drugs you must try first).
3. Ask your provider if an appeal makes sense for your reason.
4. Add the letter if it wasn’t in the first request.
5. Attach proof — BMI history, labs, what you’ve tried.
6. Watch the clock. For most private and marketplace plans, you generally have up to 180 days to file an internal appeal, and you can ask for a faster review if your health is at risk.
7. Ask whether your plan offers a peer-to-peer review — a call between your clinician and the plan’s medical reviewer. It can help when the denial turns on missing or misunderstood clinical facts.
8. Know when to stop. If your plan excludes weight-loss drugs and no other covered reason applies, switching to cash-pay can save you months.

Don’t assume a denial is final. Both Novo Nordisk and Eli Lilly publish appeal and letter resources because appeals are a normal part of getting these drugs covered — and a clear appeal that answers the plan’s exact reason often turns a “no” into a “yes.”

When cash-pay is the honest answer: your plan excludes anti-obesity drugs, you don’t meet the criteria, or the appeal will take longer than you can wait. There’s no shame in it — sometimes it’s just the faster road to starting treatment. (See your options in our guide to GLP-1 cost without insurance.)

Questions to ask before you pay

Before you join any GLP-1 program, ask whether the clinician will write or support a letter of medical necessity, who files the prior authorization, what happens if you’re denied, and whether you’ll get an itemized receipt for HSA/FSA. The answers tell you in 30 seconds whether you’ll be supported or left alone with the paperwork.

Copy and paste this before you commit:

“I’m considering a GLP-1, and my insurance or HSA/FSA may need documentation. If I’m a good fit, can your clinician write a letter of medical necessity and support a prior authorization, appeal, formulary exception, or HSA/FSA reimbursement? And who files the prior authorization — your team, the clinician, or me?”

How we verified this page

We built this page by reading provider websites, official drug-maker resources from Novo Nordisk and Eli Lilly, IRS guidance, and FDA regulatory updates. Our ranking is an editorial judgment based on documented support for letters, prior authorization, appeals, and reimbursement — not a promise that any insurer will approve you.

What we actually verified

Last verified: June 15, 2026.

• Ro’s insurance concierge checks coverage, handles prior authorization paperwork, communicates with insurers, and fights denials. Ro’s appeal guidance says appeal paperwork can include a letter of medical necessity and clinical notes. Also confirmed: Ro’s free GLP-1 insurance checker and current pricing ($39 first month; as low as $74/month with annual prepay).
• Sesame’s providers assist with prior-authorization paperwork for Wegovy and Zepbound, and that providers set their own scope and prices.
• Noom Med’s clinician provides a letter of medical necessity on request for HSA/FSA reimbursement, and Noom does not take HSA/FSA cards directly.
• Mochi Health accepts HSA/FSA cards and, per its stated policy, provides a letter of medical necessity on request for documentation, plus help with prior authorizations.
• Form Health works with most major insurance and Medicare and files prior authorizations.
• Yucca Health states it does not provide itemized receipts or letters of medical necessity.
• Novo Nordisk’s Wegovy guide and Lilly’s Zepbound guide both describe using a letter of medical necessity for prior authorization, formulary exceptions, and appeals — and both publish letter templates.
• IRS rules on weight-loss expenses (Publication 502) and the 2026 HSA/FSA limits ($4,400 individual / $8,750 family HSA; $3,400 FSA), plus the FDA’s position that compounded GLP-1s are not FDA-approved.
• Foundayo (orforglipron) was FDA-approved on April 1, 2026.

We could not verify (so confirm for your own case): exact insurance approval rates, whether a specific clinician will write a letter for a specific patient in every state, and provider response times. Pricing and policies change — we re-check this page monthly.

Frequently asked questions

This article is for general information and is not medical or tax advice. Talk with your healthcare provider about your treatment and your plan administrator or tax advisor about your benefits.

Sources

1. Ro — insurance concierge, PA + appeals, free GLP-1 insurance checker, membership pricing: ro.co/weight-loss/insurance; LMN reference: ro.co/weight-loss/insurance-stopped-covering-wegovy-glp-1/
2. Sesame — PA assistance for Wegovy/Zepbound; provider choice: sesamecare.com medication pages
3. Noom Med — clinician LMN on request for HSA/FSA; no direct HSA/FSA card: noom.com support pages
4. Mochi Health — accepts HSA/FSA cards; provides LMN on request; branded PA help: Mochi stated policy
5. Form Health — most major insurance + Medicare; files PAs: formhealth.co FAQ and coverage pages
6. Yucca Health — does not provide receipts or LMNs: Yucca FAQ
7. Wegovy LMN / formulary exception / appeals: NovoMedLink (Wegovy PA Guide; Denials & Appeals Guide)
8. Zepbound LMN / PA / appeals + template: zepbound.lilly.com (Access & Coverage; LMN composing guide)
9. HSA/FSA eligibility for weight-loss treatment: IRS Publication 502; 2026 limits: IRS Notice 2026-5 / Rev. Proc. 2025-19 ($4,400/$8,750 HSA; $3,400 FSA)
10. Compounded GLP-1 safety concerns: FDA “Concerns with Unapproved GLP-1 Drugs”
11. Compounded legal status (shortages resolved Dec 2024 / Feb 21 2025; FDA 503B bulks proposal April 30, 2026, not final): FDA / Federal Register
12. Foundayo (orforglipron) FDA approval April 1, 2026: FDA announcement; Eli Lilly; ro.co/weight-loss/foundayo